Beyond stone clearance: Redefining percutaneous biliary surgery for complex hepatolithiasis
Intractable & Rare Diseases Research · 2026
DOI: 10.5582/irdr.2026.01068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Intractable & Rare Diseases Research, 2026. Verfasst von Bo Tang und 11 weiteren Autor:innen. Die Arbeit nennt 97 Literaturangaben.
Abstract (Originalsprache)
Percutaneous transhepatic cholangioscopy (PTCS) emerged in Japan in the late 1970s as an extension of percutaneous transhepatic biliary drainage and subsequently developed into a diagnostic and therapeutic platform for hepatolithiasis, biliary strictures, and selected biliary neoplasms. Percutaneous transhepatic cholangioscopic lithotomy/ lithotripsy (PTCSL) can achieve high rates of stone clearance, but conventional treatment is limited by staged tract maturation, repeated procedures, and substantial long-term recurrence when biliary strictures and impaired drainage persist. Recent developments—including real-time ultrasound-guided puncture, rapid or one-step tract creation, rigid or hybrid cholangioscopy, active irrigation and suction, modern electrohydraulic or laser lithotripsy, and image-guided navigation—have renewed interest in the percutaneous route. In China, this integrated strategy is increasingly discussed as PTCL or, more broadly, percutaneous biliary surgery. The anatomical route itself is established; recent advances have made it a more efficient therapeutic platform. This Review focuses on complex hepatolithiasis, compares the evolving position of PTCS/PTCSL in Japanese, Chinese, and European guidance, and it examines where modern percutaneous treatment may fit between advanced endoscopy and hepatic resection. We propose a disease-oriented S–B–L–A framework—Stone burden, Biliary stricture, Liver damage, and Access—to structure patient selection. Modern percutaneous treatment may be particularly appropriate for complex, residual, or recurrent hepatolithiasis when conventional endoscopic access is difficult or unsuccessful, biliary obstruction remains potentially correctable, and the involved liver is worth preserving. Future studies should assess single-session effectiveness, cumulative treatment burden, stricture control, recurrent cholangitis, reintervention, liver preservation, and long-term recurrence in addition to final stone-clearance rates.
Zitieren
APA
Tang, B., Luo, J., Chen, P., Wei, D., Zhao, H., Hu, G., Liu, W., Su, K., Wang, L., Wang, T., Wang, Q., & Wu, T. (2026). Beyond stone clearance: Redefining percutaneous biliary surgery for complex hepatolithiasis. Intractable & Rare Diseases Research. https://doi.org/10.5582/irdr.2026.01068
Vancouver
Tang B, Luo J, Chen P, Wei D, Zhao H, Hu G, et al. Beyond stone clearance: Redefining percutaneous biliary surgery for complex hepatolithiasis. Intractable & Rare Diseases Research. 2026. doi:10.5582/irdr.2026.01068
BibTeX
@article{Tang2026,
author = {Tang, Bo and Luo, Jie and Chen, Peng and Wei, Dong and Zhao, Hai and Hu, Guang and Liu, Wei and Su, Kun and Wang, Lianmin and Wang, Tao and Wang, Qiuhong and Wu, Tao},
title = {Beyond stone clearance: Redefining percutaneous biliary surgery for complex hepatolithiasis},
journal = {Intractable & Rare Diseases Research},
year = {2026},
doi = {10.5582/irdr.2026.01068}
}
EUVIMED